Nephrology

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Latest News

Samar Abd ElHafeez | Credit: Frontiers
IgAN Among Most Common Primary Glomerular Diseases Requiring Kidney Replacement Therapy

February 19th 2024

The incidence of KRT for primary glomerular disease-induced kidney failure was greatest for IgA nephropathy and focal segmental glomerulosclerosis.

Children in classroom | Credit: Pexels
School Urinary Screening Program Facilitates Early IgAN Detection, Intervention

February 16th 2024

Armando Silva Almodovar, PharmD, MPH | Credit: LinkedIn
Inappropriate Medications Prescribed Among Patients on Dialysis

February 16th 2024

Richard Njouom, PhD | Credit: LinkedIn
HCV Prevalence, Fatality Greater Among Dialysis Patients, Especially Those on Hemodialysis

February 15th 2024

Louis-Philippe Laurin, MD, MSc | Credit: Maisonneuve-Rosemont Hospital Research Center
NanoString mRNA Profiling Identifies Inflammatory, Fibrotic Markers of IgA Nephropathy

February 10th 2024

Latest CME Events & Activities

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

Medical Crossfire®: Optimizing Care for Patients with Anemia and Chronic Kidney Disease

March 8, 2024

Register Now!

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

March 8-9, 2024

Register Now!

New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

Clinical ShowCase™ in aHUS: The Application of Complement Inhibitors in Practice

View More

Navigating Newer Approaches to Managing IgA Nephropathy

April 14, 2024

Register Now!

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities

View More

Expert Illustrations and Commentaries™: Emerging Therapies and Treatment Strategies to Improve Care for Your Patients with Anemia in CKD

View More

The Nephrology Nurse’s Role in Optimizing Outcomes for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?

View More

Community Practice Connections: 7th Annual School of Nursing Oncology™

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?

View More

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

GU Tumor Board®: Real World Strategies to Inform Individualized Care in Renal Cell Carcinoma

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.